ADAM17 Mediates Epidermal Growth Factor Receptor Transactivation and Vascular Smooth Muscle Cell Hypertrophy Induced by Angiotensin II
Open accessThe DOI matches its Crossref record.
Abstract
Background—Angiotensin II (Ang II) promotes growth of vascular smooth muscle cells (VSMCs) via epidermal growth factor (EGF) receptor (EGFR) transactivation mediated through a metalloprotease-dependent shedding of heparin-binding EGF-like growth factor (HB-EGF). However, the identity of the metalloprotease responsible for this process remains unknown. Methods and Results—To identify the metalloprotease required for Ang II-induced EGFR transactivation, primary cultured aortic VSMCs were infected with retrovirus encoding dominant negative (dn) mutant of ADAM10 or ADAM17. EGFR transactivation induced by Ang II was inhibited in VSMCs infected with dnADAM17 retrovirus but not with dnADAM10 retrovirus. However, Ang II comparably stimulated intracellular Ca 2+elevation and JAK2 tyrosine phosphorylation in these VSMCs. In addition, dnADAM17 inhibited HB-EGF shedding induced by Ang II in A10 VSMCs expressing the AT 1 receptor. Moreover, Ang II enhanced protein synthesis and cell volume in VSMCs infected with control retrovirus, but not in VSMCs infected with dnADAM17 retrovirus. Conclusion—ADAM17 activated by the AT 1 receptor is responsible for EGFR transactivation and subsequent protein synthesis in VSMCs. These findings demonstrate a previously missing molecular mechanism by which Ang II promotes vascular remodeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 30
- 2000, Pharmacol Rev, 52, 639, 10.1016/S0031-6997(24)01471-6 · DOI · Paper page
- 10.2174/156801605774322355 · DOI · Paper page
- 10.1161/hyp.29.1.366 · doi:10.1161/hyp.29.1.366
- 10.1006/jmcc.2000.1272 · DOI · Paper page
- 10.1074/jbc.273.15.8890 · DOI · Paper page
- 10.1161/01.res.0000033523.08033.16 · DOI · Paper page
- 10.1161/01.res.0000185322.46009.f5 · DOI
- 10.1038/nrm1548 · DOI · Paper page
- 10.1152/ajpheart.00062.2006 · DOI · Paper page
- 10.1074/jbc.M008570200 · DOI · Paper page
- 10.1161/res.88.1.22 · doi:10.1161/res.88.1.22
- 10.1161/res.90.2.135 · doi:10.1161/res.90.2.135
- 10.1161/01.atv.0000015903.02749.71 · DOI
- 10.1074/jbc.M408804200 · DOI · Paper page
- 10.1074/jbc.M502906200 · DOI · Paper page
- 10.1161/01.atv.0000175749.41799.9b · DOI · Paper page
- 10.1046/j.1471-4159.2002.01196.x · DOI
- 10.1038/nm0102-35 · DOI · Paper page
- 10.1128/MCB.23.5.1581-1589.2003 · DOI
- 10.1152/ajpcell.00448.2004 · doi:10.1152/ajpcell.00448.2004
- 10.1042/bst0311198 · DOI · Paper page
- 10.1074/jbc.M400129200 · DOI · Paper page
- 10.1038/nm1275 · DOI · Paper page
- 10.1161/res.87.2.92 · doi:10.1161/res.87.2.92
- 10.1161/01.res.0000147962.01036.bb · DOI
- 10.1074/jbc.M208017200 · DOI
- 10.1091/mbc.01-11-0561 · DOI · Paper page
- 10.1074/jbc.M300331200 · DOI · Paper page
- 10.1074/jbc.M306393200 · DOI · Paper page
- 10.1074/jbc.M400086200 · DOI · Paper page
Cited by
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Self-citationEndothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications
Gallo, G., Volpe, M., & Savoia, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.798958 · Cited by 446
“Ang II induces hyperplasia and hypertrophy of vascular smooth muscle cells (VSMC) in resistance arteries by modulating the endogenous production of mitogenic factors (including TGF-β (tumor growth factor-β), PDGF (platelet-derived growth factor), EGF (epidermal growth factor), IGF-1 (insulin-like growth factor 1) (38)…”
BackgroundHiguchi, S., Ohtsu, H., Suzuki, H., Shirai, H., Frank, G. D., & Eguchi, S. (2007) · Clinical Science · doi:10.1042/cs20060342 · Cited by 431
Self-citationAngiotensin II and Vascular Injury
Montezano, A. C., Nguyen Dinh Cat, A., Rios, F. J., & Touyz, R. M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0431-2 · Cited by 402
ADAM-17: the enzyme that does it all
Gooz, M. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409231003628015 · Cited by 377
Metadata
- Authors
- Ohtsu, H., Dempsey, P. J., Frank, G. D., Brailoiu, E., Higuchi, S., Suzuki, H., Nakashima, H., Eguchi, K., & Eguchi, S.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2006-09
- Volume
- 26
- Issue
- 9
- Pages
- e133-7
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2149193399
- Cited by
- 140
- References
- 0
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ADAM17 Mediates Epidermal Growth Factor Receptor Transactivation and Vascular Smooth Muscle Cell Hypertrophy Induced by Angiotensin II. https://app.cochat.ai/papers/10.1161/01.atv.0000236203.90331.d0
- The paper
- Ohtsu, H., Dempsey, P. J., Frank, G. D., Brailoiu, E., Higuchi, S., Suzuki, H., Nakashima, H., Eguchi, K., & Eguchi, S. (2006). ADAM17 Mediates Epidermal Growth Factor Receptor Transactivation and Vascular Smooth Muscle Cell Hypertrophy Induced by Angiotensin II. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.0000236203.90331.d0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.